Establishment Labs Holdings Stock
Establishment Labs Holdings Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Fillipo Peter Caldini
- Employees
- 1,004
- Market cap
- $1.8 B
- IPO
- 19/07/2018
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. Founded in 2004, the company maintains its main office in Alajuela, Costa Rica. The firm is primarily recognized for its silicone…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Establishment Labs Holdings stock: price history
1D
-3.6%
1W
-4.0%
1M
-16.8%
6M
-11.8%
YTD
-18.8%
1Y
+27.0%
2Y
+37.9%
5Y
-23.1%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~40% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Establishment Labs Holdings stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 03/09/2026.
Business model & megatrends
Not calculated yet.
1 more assignment (Enabler/Second row) Pro-only.
Establishment Labs Holdings Inc. is a specialized medical device company focused on developing and marketing products for aesthetic and reconstructive plastic surgery. Its core business is built on the Motiva brand, recognized as a trademark for innovative silicone gel implants featuring specialized gravity-responsive properties. The product portfolio also includes tissue expanders and fat transfer products (Puregraft). Global distribution is managed through a hybrid model combining an in-house sales force with exclusive distributors across the Europe, Latin America, and Asia-Pacific regions.
- Revenue model
- Hardware sales
- Recurring revenue
- None
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- Medium
- Customer concentration
- Unknown
Ask the agents about Establishment Labs Holdings
Analyst assessment of Establishment Labs Holdings
PRICE TARGET LOW
US$85.00
CONSENSUS
US$98.60
MEDIAN
US$103.00
PRICE TARGET HIGH
US$105.00
0
STRONG BUY
13
BUY
1
HOLD
0
SELL
0
STRONG SELL
14
TOTAL · Buy
As of: 15/10/2026
Establishment Labs Holdings stock metrics
P/E
-45.23
P/B
82.5
EV/EBITDA
-211.89
RETURN ON EQUITY
-54.4%
NET MARGIN
-17.4%
DEBT/EQUITY
12.2
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
91.8%
FLOAT SHARES
27,371,764
AVG. DAILY VOLUME (30D)
357,175
Insider transactions (SEC)
Custin Ann
Gillin Leslie
Slotkin Bryan
LEWIN NICHOLAS SHERIDAN
SCHUTTER EDWARD J
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -3.6%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Establishment Labs Holdings stock
What does Establishment Labs Holdings do?
Establishment Labs Holdings Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Fillipo Peter Caldini, the company employs around 1,004 people.
The IPO was on 19/07/2018; the stock trades on NASDAQ under the ticker ESTA.
What do analysts say about Establishment Labs Holdings stock?
14 analysts rate the stock, the consensus is Buy (as of 15/10/2026).
The average price target is US$98.60, ranging from US$85.00 to US$105.00, with a median of US$103.00.
This is an external assessment, not a statement by Market Jury.
When does Establishment Labs Holdings report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 40% stronger than usual.
Does Establishment Labs Holdings pay a dividend?
No, Establishment Labs Holdings currently does not pay a dividend.
Which stocks are comparable to Establishment Labs Holdings?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Establishment Labs Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Establishment Labs Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.